All articles by Joshua Silverwood

Cleerly CONFIRM2 study finds women with CAD at higher risk of MACE

Cleerly has announced interim results from a trial, described as the largest-ever cardiovascular phenotype outcomes study, finding that women living…
Sigrid’s Carb Fence tech targets patients being left behind by GLP1s

While GLP-1 receptor agonists (GLP-1RAs) are taking up attention in the weight loss market, steady, incremental progress is quietly unfolding…
Omnipod 5 improves glycaemic levels in people transitioning from daily injections

Individuals with type 1 diabetes (T1D) have demonstrated improvements in glycaemic control after transitioning away from daily insulin injections to…
Cutting calibration and consumables: new cardiac tech promises big savings

When it comes to running a hospital, minimising wastage wherever possible in pursuit of small optimisations has always been a…
Manchester EPR system rolled out to 240,000 clinicians city-wide

Attendees to a medtech conference in Manchester, UK, have heard how the region's shared care record is now being used…

Neuspera neuromodulation device hits “gold standard” in incontinence trial

Neuspera Medical’s percutaneous sacral neuromodulation (pSNM) has hit the “gold standard”, with 84.2% of patients suffering incontinence benefitting from a…
AI ethics: what are the limits in healthcare?

AI has worked its way into many industries over the past decade with no end in sight. The world of…
RFK Jr. denies being anti-vaccine during intense Senate confirmation

US President Donald Trump’s candidate for Secretary of Health and Human Services (HHS), Robert F Kennedy Jr. has been grilled…
Exact Sciences post positive results from MRD trial

Exact Sciences, has shared results from a trial of its Oncodetect test which is designed to identify the last remaining…
Boston Scientific sees success in PFA device trial

US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal…

Sections